evkeeza
ultragenyx germany gmbh - evinacumab - hiperholesterolēmija - lipīdu modificējoši aģenti - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).
ezetimibe elvim 10 mg tabletes
elvim, sia, latvia - ezetimibs - tablete - 10 mg
rosuchen 20 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 20 mg
rosuchen 40 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 40 mg
rosuchen 10 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 10 mg
rosuchen 5 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 5 mg
ezetimibe accord 10 mg tabletes
accord healthcare b.v., netherlands - ezetimibs - tablete - 10 mg
coltowan 10 mg tabletes
gedeon richter plc., hungary - ezetimibs - tablete - 10 mg
ezetrol 10 mg tabletes
merck sharp & dohme latvija, sia, latvija - ezetimibs - tabletes - 10 mg
ezetimibe pharmaswiss 10 mg tabletes
pharmaswiss ceska republika s.r.o., czech republic - ezetimibs - tablete - 10 mg